1. Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
   Mengmeng Lin et al, 2022, Journal of Oncology CrossRef
2. Recent progress in targeted therapy for non-small cell lung cancer
   Yanxia Xiao et al, 2023, Frontiers in Pharmacology CrossRef
3. Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer
   Zhoujun Lin et al, 2022, International Journal of Molecular Sciences CrossRef
4. Identification and immunological characteristics of anoikis-associated molecular clusters in lung adenocarcinoma
   Shuyan He et al, 2024, Experimental Cell Research CrossRef
5. The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents
   Gabriel da Silva et al, 2024, Gene CrossRef
6. Sphk1 deficiency induces apoptosis and developmental defects and premature death in zebrafish
   Ling Huang et al, 2023, Fish Physiology and Biochemistry CrossRef
7. The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620
   Jian-hua Zha et al, 2021, Frontiers in Oncology CrossRef
8. DNA methylation status of the SPHK1 and LTB genes underlies the clinicopathological diversity of non-alcoholic steatohepatitis-related hepatocellular carcinomas
   Noboru Tsuda et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
9. Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells
   Ling-Wei Hii et al, 2021, Frontiers in Molecular Biosciences CrossRef
10. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth
    Yuhang Xue et al, 2022, Cell Death & Disease CrossRef
11. Development and Validation of a Prognostic Autophagy-Related Gene Pair Index Related to Tumor-Infiltrating Lymphocytes in Early-Stage Lung Adenocarcinoma
    Zi-Hao Wang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
12. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
    Xinyan Li et al, 2022, Frontiers in Oncology CrossRef
13. HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1
    Xin Peng et al, 2023, Cell Death & Disease CrossRef
14. Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells
    Albena Momchilova et al, 2022, International Journal of Molecular Sciences CrossRef
15. Pharmacological Effects of FTY720 and its Derivatives
    Mengyuan Han et al, 2024, Current Topics in Medicinal Chemistry CrossRef
16. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation
    Houqing Yin et al, 2023, European Journal of Pharmacology CrossRef